Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-06-06
2006-06-06
Goldberg, Jeanine A. (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S023100
Reexamination Certificate
active
07056674
ABSTRACT:
The present invention provides gene sets the expression of which is important in the diagnosis and/or prognosis of cancer, in particular of breast cancer.
REFERENCES:
patent: 2003/0105000 (2003-06-01), Pero et al.
patent: 2004/0209290 (2004-10-01), Cobleigh et al.
patent: WO 99/02714 (1999-01-01), None
patent: WO 00/50595 (2000-08-01), None
patent: WO 00/55173 (2000-09-01), None
patent: WO 01/40466 (2001-06-01), None
patent: WO 01/55320 (2001-08-01), None
patent: WO 01/70979 (2001-09-01), None
patent: WO 02/00677 (2002-01-01), None
patent: WO 02/08260 (2002-01-01), None
patent: WO 02/08261 (2002-01-01), None
patent: WO 02/08282 (2002-01-01), None
patent: WO 02/08765 (2002-01-01), None
patent: WO 02/46467 (2002-06-01), None
patent: WO 02/055988 (2002-07-01), None
patent: WO 02/059377 (2002-08-01), None
patent: WO 02/068579 (2002-09-01), None
patent: WO 02/103320 (2002-12-01), None
patent: WO 03/083096 (2003-10-01), None
Debouck et al. “DNA microarrays in drug discovery and development.” Nature Genetics Supplement. vol. 21, pp. 48-50, Jan. 1999.
Ahmad et al. “Stromelysin 3: An independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.” Am. J. of Path. vol. 152, No. 3, pp. 721-728, Mar. 1998.
Bhattacharjee et al., “Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 24, pp. 13790-13795, Nov. 20, 2001.
Golub et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”, Science, vol. 286, pp. 531-537, Oct. 15, 1999.
Martin et al., “Linking Gene Expression Patterns to Therapeutic Groups in Breast Cancer”, Cancer Research, vol. 60, pp. 2232-2238, Apr. 15, 2000.
Ramaswamy et al., “Multiclass cancer diagnosis using tumor gene expression signatures”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 26, pp. 15149-15154, Dec. 18, 2001.
Sorlie et al., “Gene expression patterns of breast carcinomas distinguish tumor subclass with clinicl implications”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 19, pp. 10869-10874, Sep. 11, 2001.
West et al., “Predicting the clinical status of human breast cancer by using gene expression profiles”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 20, pp. 11462-11467, Sep. 25, 2001.
Yan et al., “Dissecting Complex Epigenetic Alterations in Breast Cancer Using CpG Island Microarrays”, Cancer Research, vol. 61, pp. 8375-7380, Dec. 1, 2001.
Yeang et al., “Molecular classification of multiple tumor types”, Bioinformatics, vol. 17, Suppl. 1, pp. S316-S322, 2001.
Baker Joffre B.
Bryant John L.
Paik Soonmyung
Shak Steven
Dreger Ginger R.
Genomic Health, Inc.
Goldberg Jeanine A.
NSABP Foundation, Inc.
LandOfFree
Prediction of likelihood of cancer recurrence does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prediction of likelihood of cancer recurrence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prediction of likelihood of cancer recurrence will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3652859